Pfizer Boss Gets COVID Second Time In A Month

In what can only be described as Irony on Overload, the CEO of Pfizer announced in late September that he once again tested positive for COVID-19. 

 Pfizer CEO Albert Bourla released a statement on September 24 announcing that he had COVID but said he was “feeling well” and was experiencing no symptoms. 

 This was the second time in a little over a month that the 60-year-old Bourla tested positive for COVID. 

 In mid-August, Bourla announced he was COVID positive and said he had been put on a course of Pfizer’s oral COVID antiviral treatment, Paxlovid, the go-to antiviral treatment for those in high-risk groups, including older patients. 

 Not that it works very well. 

 When President Biden contracted COVID on July 21, he was put on Paxlovid for treatment. After six days in isolation, the 79-year-old president tested negative and rushed to the Rose Garden where he held a victory lap over beating the virus. 

 Three days later, old Joe tested positive again. 

 At the time, the White House physician explained that in rare cases, patients treated with Paxlovid may experience a case of “rebound COVID.” 

 How rare can the cases be? 

 Here we have the CEO of Pfizer getting COVID-19 for the second time about a month after testing positive and getting treated with Paxlovid. 

 Like President Biden, Albert Bourla is fully vaxxed and twice boosted, and still got COVID twice. 

 When he first contracted COVID in August, Bourla expressed how grateful he was to have received four doses of his COVID vaccine. 

 For heaven’s sake why? 

 At this point, even he must realize that Pfizer’s mRNA injections are no more a vaccine than a syringe full of orange juice. 

 Meanwhile, a new variant of the vaccine has been developed by Moderna and a team from Pfizer and BioNTech that is supposed to “protect” people from the BA.5 and BA.4 Omicron subvariants that make up around 86 percent of new COVID cases in the US. 

 But if past “success” is any indication, the new vaccine probably won’t do much good.